Assignee
SHIRE VIROPHARMA INC
US·10 granted patents·7 pending applications·39 citations·filing 2014–2020
Top patents by PatentIndex Score
17 records- 0194US10080788B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Sep 25, 2018·4 cites·30 claims
- 0294US9616111B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2015·Granted Apr 11, 2017·12 cites·18 claims
- 0392US10765692B2Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2019·Granted Sep 8, 2020·4 cites·9 claims
- 0491US10485813B2Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2016·Granted Nov 26, 2019·9 cites·9 claims
- 0591US10201595B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Feb 12, 2019·2 cites·30 claims
- 0691US10130690B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Nov 20, 2018·2 cites·29 claims
- 0791US10105423B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Oct 23, 2018·2 cites·29 claims
- 0874US2019160158A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2018·Application pending·0 cites
- 0972US9895428B2Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2014·Granted Feb 20, 2018·2 cites·27 claims
- 1069US10272142B2Compositions and methods useful for the treatment of neuromyelitis optica spectrum disordersSHIRE VIROPHARMA INC·Filed 2014·Granted Apr 30, 2019·2 cites·17 claims
- 1169US2017224788A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 1260US2016175338A1Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2016·Application pending·0 cites
- 1359US2020360495A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2020·Application pending·0 cites
- 1457US10583146B2Pharmaceutical compositions for glucocorticoid replacement therapySHIRE VIROPHARMA INC·Filed 2014·Granted Mar 10, 2020·0 cites·23 claims
- 1555US2016304549A1Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-l-ribofuranosyl)-1h-benzimidazoleSHIRE VIROPHARMA INC·Filed 2016·Application pending·0 cites
- 1650US2018104319A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 1746US2016106786A1Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and useSHIRE VIROPHARMA INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →